# OnCo record eric-jonasch (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/eric-jonasch/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "eric-jonasch" ;
  schema:name "Eric Jonasch"@en ;
  schema:description "Houston oncologist who led the trial that established belzutifan, the first drug for the tumours of von Hippel-Lindau disease, including kidney cancers, pancreatic tumours and haemangioblastomas."@en ;
  schema:url <https://onco.cc/people/eric-jonasch/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "kidney", "targeted-therapy", "trialist" ;
  schema:jobTitle "Genitourinary medical oncologist, MD Anderson Cancer Center" ;
  onco:cancers <https://onco.cc/cancers/spinal-cord-tumours/>, <https://onco.cc/cancers/clear-cell-rcc/>, <https://onco.cc/cancers/rcc/> ;
  onco:institutions <https://onco.cc/institutions/md-anderson/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-belzutifan-vhl-jonasch-nejm-2021/> ;
  schema:affiliation <https://onco.cc/institutions/md-anderson/> .